首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Japanese journal of clinical oncology

缩写:JPN J CLIN ONCOL

ISSN:0368-2811

e-ISSN:1465-3621

IF/分区:2.5/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引4042条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sosuke Omizo,Takuma Narita,Tomoko Hamaya et al. Sosuke Omizo et al.
Objective: Anti-androgen therapy is central to prostate cancer management, but nationwide real-world trends in prescribing and costs remain insufficiently characterized in aging societies. We evaluated temporal trends in ...
Kumiko Ui-Tei Kumiko Ui-Tei
Small interfering RNA (siRNA) therapeutics have emerged as a promising class of nucleic acid-based medicines that selectively suppress the expression of disease-associated genes by targeting messenger RNAs (mRNAs). Unlike conventional small...
Keita Hayakawa,Takashi Ueda,Yusuke Gabata et al. Keita Hayakawa et al.
Background: Androgen receptor signaling inhibitors (ARSI) and docetaxel (DTX) are standard treatments for metastatic castration-resistant prostate cancer (mCRPC). However, the differences in therapeutic efficacy between t...
Myo Min Khant,Masaki Fujiwara,Yuto Yamada et al. Myo Min Khant et al.
Background: Patients with schizophrenia spectrum disorders (SSD) experience higher cancer mortality, partly because of later-stage diagnosis and lower rates of recommended treatments. While treatment disparities have been...
Takeshi Murata,Tomomi Fujisawa,Fumikata Hara et al. Takeshi Murata et al.
Breast cancer treatment is rapidly evolving toward precision-based de-escalation strategies for oncological safety and minimizing treatment-related morbidity. In early stage disease, minimally invasive approaches, such as non-surgical ablat...
Connor Frey Connor Frey
Immune effector cell-associated hematotoxicity is a recognized but incompletely characterized complication of chimeric antigen receptor T-cell (CAR-T) therapy, defined by prolonged, severe, or recurrent cytopenias following CAR-T infusion, ...
Kota Kawabata,Koichi Yasuda,Satoaki Nakamura et al. Kota Kawabata et al.
Chemoradiotherapy (CRT) with high-dose cisplatin (100 mg/m2) is the standard treatment for locally advanced squamous cell carcinoma of the head and neck (SCCHN). However, this regimen is often intolerable in elderly patients because of its ...
Issei Imoto,Nobue Takaiso,Akiyo Yoshimura et al. Issei Imoto et al.
Multigene panel testing has become an important component of hereditary cancer evaluation in Western practice. This shift has been driven by advances in next-generation sequencing, declining costs, and the increasing relevance of germline f...
Shinya Hiraoka,Takeshi Kodaira,Nobuhiro Hanai et al. Shinya Hiraoka et al.
Head and neck squamous cell carcinoma (HNSCC) often requires invasive multimodal therapy, including surgery, radiotherapy, and chemotherapy. Although these interventions have improved treatment outcomes, patients frequently experience long-...